HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dalia L Rotstein Selected Research

Headache (Headaches)

7/2018Severe aseptic temporal lobe encephalitis on fingolimod.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dalia L Rotstein Research Topics

Disease

5Multiple Sclerosis
01/2020 - 05/2010
2Optic Neuritis (Retrobulbar Neuritis)
01/2022 - 01/2020
2Encephalitis (Encephalitis, Rasmussen)
07/2018 - 01/2016
1Schizophrenia (Dementia Praecox)
01/2022
1Autoimmune Diseases of the Nervous System
01/2022
1Cognitive Dysfunction
01/2022
1Hallucinations (Hallucination)
01/2022
1Demyelinating Diseases (Demyelinating Disease)
01/2020
1Transverse Myelitis (Necrotizing Myelitis)
01/2020
1Neoplasms (Cancer)
01/2020
1Stroke (Strokes)
01/2020
1Headache (Headaches)
07/2018
1Virus Diseases (Viral Diseases)
07/2018
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
09/2014

Drug/Important Bio-Agent (IBA)

2Fingolimod Hydrochloride (FTY720)FDA Link
07/2018 - 12/2015
2Glatiramer Acetate (Copaxone)FDA Link
12/2015 - 05/2010
1AntibodiesIBA
01/2022
1Rituximab (Mabthera)FDA Link
01/2022
1eculizumabFDA Link
01/2022
1Myelin-Oligodendrocyte GlycoproteinIBA
01/2020
1Imatinib Mesylate (Gleevec)FDA Link
01/2020
1Tyrosine Kinase InhibitorsIBA
01/2020
1Immunoglobulin G (IgG)IBA
01/2020
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2016
1InterferonsIBA
12/2015
1Vitamin DFDA LinkGeneric
12/2015
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
09/2014
1Natalizumab (Tysabri)FDA Link
05/2010
1Interferon beta-1aFDA Link
05/2010
1Interferon beta-1b (Betaseron)FDA Link
05/2010

Therapy/Procedure

4Therapeutics
01/2022 - 09/2014
1Activities of Daily Living (ADL)
01/2022
1Immunotherapy
01/2022
1Plasma Exchange
01/2020